Further evidence for botulinum toxin A in cerebral palsy

Affiliations

¹ Division of Neurology, Department of Pediatrics, University of Toronto, Toronto, Ontario, Canada; The Hospital for Sick Children, Toronto, Ontario, Canada.
² Division of Developmental Pediatrics, Department of Pediatrics, University of Toronto, Toronto, Ontario, Canada; Holland Bloorview Kids Rehabilitation Hospital, Toronto, Ontario, Canada; Bloorview Research Institute, Toronto, Ontario, Canada.
³ Division of Neurology, Department of Pediatrics, University of Toronto, Toronto, Ontario, Canada; The Hospital for Sick Children, Toronto, Ontario, Canada; Neurosciences and Mental Health Program, SickKids Research Institute, Toronto, Ontario, Canada. Electronic address: steven.miller@sickkids.ca.

Editorial

Vann Chau et al. J Pediatr. 2014 Jul.

. 2014 Jul;165(1):15-7.

doi: 10.1016/j.jpeds.2014.03.041. Epub 2014 Apr 27.

¹ Division of Neurology, Department of Pediatrics, University of Toronto, Toronto, Ontario, Canada; The Hospital for Sick Children, Toronto, Ontario, Canada.
² Division of Developmental Pediatrics, Department of Pediatrics, University of Toronto, Toronto, Ontario, Canada; Holland Bloorview Kids Rehabilitation Hospital, Toronto, Ontario, Canada; Bloorview Research Institute, Toronto, Ontario, Canada.
³ Division of Neurology, Department of Pediatrics, University of Toronto, Toronto, Ontario, Canada; The Hospital for Sick Children, Toronto, Ontario, Canada; Neurosciences and Mental Health Program, SickKids Research Institute, Toronto, Ontario, Canada. Electronic address: steven.miller@sickkids.ca.

No abstract available

Comment on

Botulinum toxin A for nonambulatory children with cerebral palsy: a double blind randomized controlled trial.
Copeland L, Edwards P, Thorley M, Donaghey S, Gascoigne-Pees L, Kentish M, Cert G, Lindsley J, McLennan K, Sakzewski L, Boyd RN. Copeland L, et al. J Pediatr. 2014 Jul;165(1):140-146.e4. doi: 10.1016/j.jpeds.2014.01.050. Epub 2014 Mar 12. J Pediatr. 2014. PMID: 24630348 Clinical Trial.